Quarterly report pursuant to Section 13 or 15(d)

3. RESTATEMENT (Details)

v2.4.0.8
3. RESTATEMENT (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Condensed Consolidated Balance Sheet          
Intangible assets (net) $ 3,562,000   $ 3,562,000    
Goodwill 1,855,512   1,855,512    
Amount due under the PhytoSPHERE Agreement 1,314,878   1,314,878   0
Additional paid in capital 6,535,495   6,535,495   143,447
Accumulated deficit (620,578)   (620,578)   (144,216)
Condensed Consolidated Statement of Operations          
General and administrative expenses 653,872 8,875 1,267,266 36,271  
Impairment of goodwill 0   0    
Research and development expenses 137,496 0 137,496 0  
Net income (loss) (810,761) (9,839) (476,362) (39,087)  
Earnings per share $ (0.08) $ 0.00 $ (0.05) $ (0.01)  
Condensed Consolidated Statement of Cash Flows          
Net income (loss) (810,761) (9,839) (476,362) (39,087)  
Amortization expense 205,500   548,000 0  
Impairment of goodwill 0   0    
Scenario, Previously Reported [Member]
         
Condensed Consolidated Balance Sheet          
Intangible assets (net) 4,466,666   4,466,666    
Goodwill 0   0    
Amount due under the PhytoSPHERE Agreement 6,499,998   6,499,998    
Additional paid in capital 28,330,375   28,330,375    
Accumulated deficit (28,551,425)   (28,551,425)    
Condensed Consolidated Statement of Operations          
General and administrative expenses 1,115,098   2,337,484    
Impairment of goodwill 26,998,125   26,998,125    
Research and development expenses 0   0    
Net income (loss) (28,132,616)   (28,407,209)    
Earnings per share $ (2.81)   $ (3.21)    
Condensed Consolidated Statement of Cash Flows          
Net income (loss) (28,132,616)   (28,407,209)    
Amortization expense     1,480,722    
Impairment of goodwill 26,998,125   26,998,125    
Scenario, Adjustment [Member]
         
Condensed Consolidated Balance Sheet          
Intangible assets (net) (904,666)   (904,666)    
Goodwill 1,855,512   1,855,512    
Amount due under the PhytoSPHERE Agreement (5,185,120)   (5,185,120)    
Additional paid in capital (21,794,880)   (21,794,880)    
Accumulated deficit 27,930,846   27,930,846    
Condensed Consolidated Statement of Operations          
General and administrative expenses (461,226)   (1,070,218)    
Impairment of goodwill (26,998,125)   (26,998,125)    
Research and development expenses 137,496   137,496    
Net income (loss) 27,321,855   27,930,847    
Earnings per share $ 2.73   $ 3.16    
Condensed Consolidated Statement of Cash Flows          
Net income (loss) 27,321,855   27,930,847    
Amortization expense     (932,722)    
Impairment of goodwill $ (26,998,125)   $ (26,998,125)